{
  "abstract": "Metabolic dysfunction-associated steatotic liver disease (MASLD) is now the most common chronic liver disease in the world [...]",
  "abstract_shown": true,
  "affiliations": [
    "Department of Internal Medicine, Dell Medical School, The University of Texas at Austin, Austin, TX 78712, USA"
  ],
  "article_type": null,
  "arxiv": null,
  "author_total": 1,
  "authors": [
    {
      "affs": [
        0
      ],
      "name": "Hirsh D. Trivedi",
      "orcid": "0000-0002-8328-9211"
    }
  ],
  "bibtex": "https://research.draconitic.com/paper/cyj5w3qa76fy0.bib",
  "cited_by": 0,
  "doi": "10.3390/jcm15218634",
  "fulltext_url": null,
  "id": "cyj5w3qa76fy0",
  "issns": [
    "2077-0383"
  ],
  "landing_url": "https://www.mdpi.com/2077-0383/15/21/8634",
  "language": null,
  "licence": "CC-BY-4.0",
  "licence_label": "CC BY 4.0",
  "licence_source": "article",
  "licence_url": "https://creativecommons.org/licenses/by/4.0/",
  "metadata_licence": null,
  "native_subjects": [],
  "openalex": null,
  "pdf_url": null,
  "pmcid": null,
  "pmid": null,
  "published": "2026-11-05",
  "publisher": "MDPI AG",
  "ris": "https://research.draconitic.com/paper/cyj5w3qa76fy0.ris",
  "sources": [
    {
      "first_seen": "2026-11-06T00:21:25Z",
      "native_id": "10.3390/jcm15218634",
      "source": "crossref",
      "url": "https://www.mdpi.com/2077-0383/15/21/8634"
    }
  ],
  "subjects": [
    {
      "field": "medicine",
      "origin": "journal-openalex:F27",
      "subfield": "general"
    }
  ],
  "title": "Clinical Advances in Metabolic Dysfunction-Associated Steatotic Liver Disease: Context, Measurement, and Treatment",
  "title_text": "Clinical Advances in Metabolic Dysfunction-Associated Steatotic Liver Disease: Context, Measurement, and Treatment",
  "type": "peer-reviewed",
  "updated_at": "2026-11-07T00:21:23Z",
  "url": "https://research.draconitic.com/paper/cyj5w3qa76fy0",
  "venue": "Journal of Clinical Medicine",
  "versions": []
}